|
Letter to CMS Regarding BMT Codes (December 19, 2006)
ASH-ASCO Joint Letter on RUC Composition (November 30, 2006)
Sign-on Letter to Representatives Regarding Medicare Reimbursement (November 13, 2006)
Sign-on Letter to Senators Regarding Medicare Reimbursement (November 13, 2006)
ASH Letter to Senate Regarding NIH Reauthorization (November 13, 2006)
Sign-on letter to CMS on consultation policy (October 20, 2006)
ASH Medicare HOPPS Comments (October 10, 2006)
ASH Medicare Fee Schedule Comments (October 10, 2006)
Comments on 5-Year Review and Practice Expense Methodology Proposed Rule (August 21, 2006)
Clinical Trials Policy Reconsideration (CAG-00071R) Letter to CMS (August 9, 2006)
ASH Letter to President George
W. Bush Regarding Stem Cell Research Enhancement Act (HR 810) (July 19,
2006)
Sign-On Letter to U.S. Senators
Regarding Stem Cell Research Enhancement Act (HR 810) (July 14, 2006)
ASH
Letter to U.S. Senate Regarding Stem Cell Research Enhancement Act (HR 810)
(July 11, 2006)
Sign-On Letter
to CMS on Medically Unbelievable Edits (April 12, 2006)
ASH Comments
on Medicare Practice Expense Methodology (March 24, 2006)
Sign-On
Letter to U.S. Senate Regarding the Specter-Harkin Amendment (March
16, 2006)
ASH Comments
on United Government Services Draft Policy (March 16, 2006)
ASH MedPAC
Nomination Letter (February 16, 2006)
HOPPS
Final Rule Comments (January 9, 2006)
Archive
2005 Testimony & Correspondence
2004 Testimony & Correspondence
2003 Testimony & Correspondence
|